Considering that oxidative stress is increased in inflammatory skin conditions, anti-oxidative AhR agonists are particularly promising in drug development for AD in which inflammation, barrier disruption, and oxidative stress have a combination effect. This evidence concerns the gene AHR and Alzheimer disease.